Showing results (271-280 of 571) with videos related to

Sort By:
Pageof 58
Cancer Chemotherapy and Pharmacology|February 5, 2013
A phase I study of hepatic arterial infusion of nab-paclitaxel in combination with intravenous gemcitabine and bevacizumab for patients with advanced cancers and predominant liver metastasesApostolia M Tsimberidou, Yang Ye, Jennifer Wheler, et al.
Plos One|November 1, 2011
BRAF mutations in advanced cancers: clinical characteristics and outcomesHazem El-Osta, Gerald Falchook, Apostolia Tsimberidou, et al.
Investigational New Drugs|June 1, 2014
Investigational Aurora A kinase inhibitor alisertib (MLN8237) as an enteric-coated tablet formulation in non-hematologic malignancies: phase 1 dose-escalation studyGerald Falchook, Razelle Kurzrock, Launce Gouw, et al.
Nutrition and Cancer|January 11, 2012
Evaluation of the clinical relevance of body composition parameters in patients with cancer metastatic to the liver treated with hepatic arterial infusion chemotherapyHenrique A Parsons, Apostolia M Tsimberidou, Michael Pontikos, et al.
Cancer Immunology Research|January 26, 2023
Inhibition of STAT6 with Antisense Oligonucleotides Enhances the Systemic Antitumor Effects of Radiotherapy and Anti-PD-1 in Metastatic Non-Small Cell Lung CancerKewen He, Hampartsoum B Barsoumian, Nahum Puebla-Osorio, et al.
Brachytherapy|January 4, 2025
Early outcomes following local salvage treatment with MRI-assisted low-dose rate brachytherapy (MARS) for MRI-visible postsurgical bed recurrences and focal intraprostatic recurrencesComron Hassanzadeh, Osama Mohamad, Teresa Bruno, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2019
Dose Escalation for Prostate Adenocarcinoma: A Long-Term Update on the Outcomes of a Phase 3, Single Institution Randomized Clinical TrialDario Pasalic, Deborah A Kuban, Pamela K Allen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 8, 2023
Outcomes after PD-103 versus I-125 for low dose rate prostate brachytherapy monotherapy: An international, multi-institutional studyChad Tang, Jeremiah Sanders, Howard Thames, et al.
Elife|November 9, 2021
Early prediction of clinical response to checkpoint inhibitor therapy in human solid tumors through mathematical modelingJoseph D Butner, Geoffrey V Martin, Zhihui Wang, et al.
Gynecologic Oncology|March 30, 2010
Phase I clinical trials in 85 patients with gynecologic cancer: the M. D. Anderson Cancer Center experienceJohn Moroney, Jennifer Wheler, David Hong, et al.
Pageof 58